PRME compared with PAYP: revenue, margins and what each company keeps, and the suppliers and customers both name

PRMEPrime Medicine, Inc.

Mkt capRevenueRevenue

PAYPPayPay Corp

Mkt capRevenueRevenue

Compare

PRMEPrime Medicine, Inc.

PAYPPayPay Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PRME

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.2%▼−4.22%×0.30

May 7 '26±15.5%▼−8.65%×0.56

Q1 FY26±18.4%▼−9.23%×0.50

Q3 FY25±17.6%▼−8.85%×0.50

PAYP1 of 4 reports

Reportimpliedrealized× implied

Nov 4 '26—▲+8.50%—

= impliedPRME realized, solidPAYP realized, hatchedOne scale, both sides: full bar = 19%× = |realized| ÷ impliedSource: market data

PRMEPrime Medicine, Inc.

4.45▼−10.45%· post 4.30

Mkt cap—Revenue$1MQ2 FY26Revenue$5MFY25

PAYPPayPay Corp

14.63▼−8.30%· post 14.45

ClosedNov 5 '26

Mkt cap$10.8BRevenue—Revenue—

Compare

ClosedNov 5 '26

PRMEPrime Medicine, Inc.

PAYPPayPay Corp

4.45▼−10.45%post 4.30

Price

14.63▼−8.30%post 14.45

—

Mkt cap

$10.8B

Q2 FY26$1M

Revenue

—

FY25$5M

Revenue

—

PRME4.45▼−10.45%vsPAYP14.63▼−8.30%ClosedNov 5 '26